When Dean Ho looks into the future, he sees a world where more people have access to higher quality healthcare at lower costs. Some may call him an optimist, but the research director is in a better position than most to believe in this somewhat utopian vision.
As director at a research institute that is personalising patient care and using digital medicine to usher in a new frontier of healthcare, Dr Ho is leading efforts to develop artificial intelligence (AI)-based solutions to design clinical trials for various purposes, including novel drug development and more recently, formulating optimal drug combinations to treat the Covid-19 virus.
Dr Ho, 41, who moved to Singapore with his family from the United States in 2018, says: "We are working hard to scale the validation, deployment, and implementation of our AI-based platforms.
"One of our major goals is to demonstrate that we can dramatically reduce the cost of optimal drug combination development, with orders of magnitude reduction in costs and bringing AI-optimised treatment outcomes to patients years faster, particularly in the area of oncology. We are excited about what's on the horizon."
His team has been using a platform called IDentif.AI to determine optimal combination therapies that can be clinically-administered to treat Covid-19 patients. "From our first studies, we were able to identify an extensive list of possible combinations, ranked based on their efficiency at countering infection from a patient-derived SARS-CoV-2 live virus."
This list enables clinicians to select potential combinations that may or may not contain certain drugs due to drug shortages or a patient's pre-existing conditions. "This allows for a substantial level of actionability and versatility for clinicians, as they have a broad spectrum of treatment options," he explains.
The response has been encouraging so far. Already, multiple clinical communities across the globe have reached out to his team for their results, which have provided helpful guidance.
The team ultimately aims to work with multiple partners to develop IDentif.AI-pinpointed combinations based on a large collection of potential therapies. They also plan to develop a public database of these combinations for the benefit of the community. "In the event we need additional combinations in the future, we will be ready," he says.
Curating precision treatments
Dr Ho's pandemic-related work is just part of his broader mission to leverage technologies such as AI and nanotechnology to create precision and personalised medicine for the benefit of patients.
One of his more notable achievements is the creation of Curate.ai, an AI platform developed over about five years by a research team led by Dr Ho. As each individual's response to medication is unique and changing, Curate.ai uses a patient's data - such as how a tumour changes in size following a certain drug dosage - to generate a profile that is able to recommend the optimal drug dosage for this person at any point in time.
This method of dosing is designed to improve the efficacy and safety of treatments.
In 2018, Curate.ai's recommended drug dosage for a prostate cancer patient successfully reduced the size of his tumour. According to Dr Ho, his team's AI solutions are unique in that they use actual experimental data from studies to optimise the right drugs and doses. As a result, these platforms have already been taken to the clinic for multiple studies, he reveals.
"Importantly, by rapidly optimising how we develop these treatments or administer these treatments, we have an opportunity to markedly accelerate the delivery of these optimised therapies to patients, potentially reducing the cost of care while realising substantially improved treatment outcomes. Of note, our AI platforms can be broadly deployed against a broad spectrum of disease indications, so that we can continue to help as many patients as possible," he says.
Going big with nanotech
Dr Ho is also a pioneer in nanomedicine, with his team spearheading the use of nanoscopic "diamonds" that carry drugs to diseased cells in the body to treat cancer. Together with collaborators, they also developed a magnetic resonance imaging agent that dramatically improves imaging brightness, substantially reducing the amount of imaging agent required.
"Nanotechnology is exciting because the materials that we use are versatile and can be coated with a broad spectrum of therapies as well as imaging agents, and these nanomaterials can often markedly improve the efficiency and safety of drug treatment or imaging efficiency," explains Dr Ho.
For his AI-related work in personalised and precision medicine, as well as in the areas of nanomedicine, Dr Ho was the only Singapore-based academic inventor elected in 2018 as a fellow of the United States National Academy of Inventors, the highest professional accolade for academic inventors.
"I'm hoping that our aspirations of redefining the status quo in healthcare, and making practice-changing advances in medicine will have helped as many people as possible."
One of Dr Ho's clinical trials was a collaborative project with his father focused on optimising drug therapy for liver transplant patients to prevent organ rejection.
"We were able to use AI to recommend appropriate dosages, but not only that, we could see an immediate and real benefit: patients could be discharged from intensive care up to a month earlier," he says.
"It was amazing to work with my dad to realise these outcomes for patients."
Indeed, the father of two aligns his work closely with how he views family. "We're often approached by families and communities who need help for a loved one.
"As a father, I want my children to know I'll always be there to help them when they need it. That's the same hope I have for the technologies we've developed."
Dr Ho was born and raised in Los Angeles and attended the University of California, Los Angeles (UCLA), graduating with a PhD in biomedical engineering. Before relocating to Singapore in 2018, he spent six years as a professor at UCLA.
His parents had migrated to the United States to pursue their education, and he learnt from them the importance of using one's achievements to give back to society. His father was a career innovator in various fields, from biomedical to aerospace engineering, and treated his team as family, while his mother is a gifted artist and speaker.
"My parents were a huge inspiration for me growing up. Both of my parents inspired me to give back to the community, and being surrounded by their diverse strengths has been amazing," he says.
His experiences growing up also taught him the importance of fostering a close-knit team at work, and being a responsible and nurturing parent and husband. He describes his son Ethan as an inquisitive child who adores sharks and all marine creatures, while his daughter is free-spirited and creative. He met his wife, Sarah Ahn, in college when both of them were pursuing biomedical doctorates, although she would later switch careers to study fashion design and establish her own label, NAMI.
It takes a village
Several months after the family moved to Singapore, Dr Ho's wife was diagnosed with a brain tumour. "After my wife's diagnosis, I was completely and utterly lost. I'm usually the one who knows what's next, because that's what I do. Now we were on the other side."
Thankfully, with the help of their community, Sarah was able to recover. "It takes a community to weather adversity. The minute we found out about Sarah's diagnosis, I was on the phone with so many people who went on to collectively play a role in saving her life and getting her back on her feet.
"We were away from our immediate family, but our community of supporters became a new family for us. We are so deeply grateful for that," he recalls.
Dr Ho believes that community will also be key in achieving his goal of advancing healthcare, as it will take a collective effort from different stakeholders in the sector's ecosystem. "Our team strongly believes that technology alone won't markedly advance healthcare. It takes the seamless integration of multiple disciplines and skill sets."
He notes that a key challenge in his work is to pair the AI platforms his team has developed with stakeholders that will play a vital role in ensuring that they can be integrated into healthcare workflows.
This includes doctor and nursing teams, healthcare economists, behavioural scientists, regulators, payer and reimbursement communities, as well as the patients and patient advocacy groups, among many others.
He cites these partners, as well as his own team members, as inspirations. "I consider this community my family, and collaborating with them has been an honour. Our work together is a mutual learning experience, and it has taken mutual inspiration to bring us to the point where we are now seeing the promise of clinical impact."
Leaving a legacy
While Dr Ho is well on his way to making a mark in the healthcare world, he is also focused on crafting a legacy that is far more personal in nature; and that is to ensure that his children have the means to achieve their own dreams.
He says: "To me, legacy planning means having the foresight to think ahead and provide peace of mind for our future generations so that they won't have to worry about not having the necessary means to support their aspirations. In the case of our children, we want to solidify their access to the financial means for limitless educational goals."
Crafting a legacy across generations
WHETHER it's as bold as changing the future of healthcare, or as intimate as giving your loved ones the means to realise their dreams, there are many paths to crafting one's legacy.
Whatever form it takes, your legacy is a testimony that deserves to live on.
At Opus by Prudential, we understand that it sometimes takes a community to help you make a lasting impact. That's why we offer you seamless support and services to take care of your wealth planning and protection needs - from VIP medical services at one of Singapore's finest healthcare clinics to swift underwriting and dedicated case management, plus access to our panel of value-added services advisors.
Dr Dean Ho is one client who has experienced the exceptional support that Opus professionals can provide. "When my wife, Sarah, was diagnosed with a brain tumour, our family's shock was extraordinarily disorienting. Estella, our Opus Financial Consultant, was one of the very first people we spoke to," recalls Dr Ho. "Her being there for us in the very beginning was an amazing source of security for us. She helped us navigate the process of preparing our documents, but most of all, she became family during the process.
"She was always accessible, and would often check in with us to ask if there was any way that she could help."
With our tailored expertise, Opus by Prudential can help you uniquely plan and preserve your wealth, protect your assets, safeguard your health and retire with ease. No matter what path you take, or how you wish to be remembered, we can help you forge a legacy that will make its mark across generations.
Find out more about legacy planning from an Opus by Prudential Private Wealth Consultant
- $700 Million Worth of Synthetic Bitcoin Is Circulating on the Ethereum Blockchain - Bitcoin News - September 8th, 2020
- Exclusive mining could have negative implications for the Blockchain industry, say experts - Cointelegraph - September 8th, 2020
- Reimagining blockchain for healthcare solutions with the MAXathon - Health Europa - September 8th, 2020
- All fintech companies will use blockchain within 10 years: Aussie government report - Cointelegraph - September 8th, 2020
- 'Decentralized Reddit' enables users to secure Twitter on the blockchain - Cointelegraph - September 8th, 2020
- Former Georgian PM: Blockchain is the steam engine of Industry 4.0 - Cointelegraph - September 8th, 2020
- How will decentralized blockchain technology evolve in the future? - Gary Skentelbery - September 8th, 2020
- How the Bitcoin Blockchain Is Being Used to Safeguard Nuclear Power Stations - CoinDesk - CoinDesk - September 8th, 2020
- Starbucks' Deployment of a Blockchain Network May Show Restaurants the Way to Future Revenue Growth | - Restaurant Technology News - September 8th, 2020
- Nanomedicine Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis And Forecast To 2026 |... - September 5th, 2020
- Healthcare Nanotechnology (Nanomedicine) Market : Updates, Future Growth, Industry Analysis And Comprehensive Study On Key Players To 2020 2028 -... - September 5th, 2020
- Nanomedicine Market Segmentation By Qualitative And Quantitative Research Incorporating Impact Of Economic And Non-Economic Aspects By 2027 - Reports... - September 5th, 2020
- Impressive Trends and Future Scope of Nanocapsules Market - StartupNG - September 5th, 2020
- NanoViricides is Developing Drugs Against SARS-CoV-2 with an Integrated Approach to Combat COVID-19, as Reported at The LD 500 Virtual Conference -... - September 5th, 2020
- Clene Nanomedicine, researching the use of gold atoms to slow ALS progression, nets $42.5M Series D - Endpoints News - September 2nd, 2020
- Amorphous Soft Magnetic Materials Market to Reach USD 728.5 Million by 2027; Need to Blend Amorphous & Nano-crystalline Alloys will Favor Growth,... - September 2nd, 2020
- 5 Recent Tech Innovations Disrupting the Medical and Healthcare Industry - HealthTechZone - September 2nd, 2020
- Mohali INST scientists develop new nano-particle-based treatment for kala azar - The Tribune India - August 21st, 2020
- Book Review: What Can India's Embrace of Nanotech Tell Us About India's Science? - The Wire Science - August 21st, 2020
- Healthcare Nanotechnology (Nanomedicine) Market Analysis, Key Players, Industry Segments And Forecast To 2026 - The News Brok - August 21st, 2020
- Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region - Good Night, Good Hockey - August 21st, 2020
- New 'molecular computers' find the right cells - UW Medicine Newsroom - August 21st, 2020
- How can nanomedicine be applied to cannabis? - Leafly - August 10th, 2020
- Global Healthcare Nanotechnology (Nanomedicine) Industry Outlook 2020-2027 with Profiles of 46 Players Including Abbott Labs, Celgene Corp, GE... - August 10th, 2020
- Global Projection 2020: Nanomedicine Market Exclusive Profitable Comprehensive Research Report with COVID-19 Impact Overview | Forecast 2029 - News... - August 10th, 2020
- Green One-Step Synthesis of Medical Nanoagents for Advanced Radiation | NSA - Dove Medical Press - August 10th, 2020
- Nanomedicine - Wikipedia - August 10th, 2020
- What is Nanomedicine? : Center for Nanomedicine - August 10th, 2020
- Nanomedicine | medicine | Britannica - August 10th, 2020
- Nanomedicine - an overview | ScienceDirect Topics - August 10th, 2020
- Cleaning the Nano-Texture Glass on Your New iMac - The Mac Observer - August 10th, 2020
- COVID-19 was created in the Wuhan laboratory and is now in the hands of the Chinese military - Malaysian Christian News - August 10th, 2020
- Nanomedicine Market To Reach USD 343.8 Billion By 2026 | CAGR of 12.6% - PharmiWeb.com - August 8th, 2020
- Nanomedicine Market Actual Strategies of Key Players to Overcome COVID 19 Pendamic | GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck... - August 5th, 2020
- What happens when bacteria resist treatment? Trobix lands $3M to protect us from next 'Super Bug' - Geektime - August 5th, 2020
- Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys - Science Advances - August 5th, 2020
- Global Healthcare Nanotechnology (Nanomedicine) Market Worth $475B by 2027 - Therapeutics Will Account for $369B - Benzinga - August 5th, 2020
- Global Nanotechnology in Medical Market 2020 Comprehensive analysis with Top Trends, Size, Share, Future Growth Opportunities & Forecast by 2027... - August 2nd, 2020
- Researchers uncover how cells interact with supporting proteins to heal wounds | The Source - Washington University in St. Louis Newsroom - August 2nd, 2020
- Nanomedicine Market Provides in-depth analysis of the Nanomedicine Industry, with current trends and future estimations to elucidate the investment... - July 31st, 2020
- Global Nano Therapy Market- Industry Analysis and Forecast (2020-2027)-by, Type, Application, and Region. - Red & Black Student Newspaper - July 31st, 2020
- Nanomedical Market 2019 | How The Industry Will Witness Substantial Growth In The Upcoming Years | Exclusive Report By MRE Bulletin Line - Bulletin... - July 31st, 2020
- BIOPHARMACEUTICAL AND BIOMEDICINE MARKET RESEARCH, OPPORTUNITIES, EMERGING TRENDS, COMPETITIVE STRATEGIES AND FORECASTS 2016-2028 | AMGEN INC., F.... - July 31st, 2020
- Nanomedicine Market Report (2019-2027) | The demand for the Market will drastically increase in the Future? - Research Newspaper - July 31st, 2020
- Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy - DocWire News - July 29th, 2020
- New insights into wound healing - Newswise - July 29th, 2020
- Seer raises another $55M and finally reveals proteomic tech can it hold up? - Endpoints News - July 29th, 2020
- Tracked the behavior of nanoparticles in the body - FREE NEWS - July 29th, 2020
- CLR 131 Leads a New Generation of Lipid-Based Cancer Drug Delivery Systems - OncLive - July 24th, 2020
- Nanomedicine Market 2019 by Rising-Trends, Growth Analysis, Industry Share, Product Types, User-Demand, Business Strategy and Comprehensive Valuation... - July 24th, 2020
- Nanomedicine Market Competitive Research And Precise Outlook 2020 To 2026 - Cole of Duty - July 24th, 2020
- Global Nanotechnology in Medical Market is Expected to Grow at Moderate Pace by 2027 Post COVID 19 Pandemic, Latest Market Research Report by... - July 24th, 2020
- Small AI biotech BioXcel surges on positive PhIII results, setting up dementia and Alzheimer's test - Endpoints News - July 24th, 2020
- How research groups are tackling the problem of biologic drug delivery - Pharmaceutical Technology - July 22nd, 2020
- NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020 - BioSpace - July 22nd, 2020
- Investigating the Effect of Nano-Curcumin on the Expression of Biofilm | IDR - Dove Medical Press - July 20th, 2020
- Coronavirus news: Understanding the relationship between nanotechnology and COVID-19 - Free Press Journal - July 19th, 2020
- Healthcare Nanotechnology (Nanomedicine) Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And... - July 19th, 2020
- THE 1918 PANDEMIC: What Happened When the Flu Overwhelmed Humboldt's Medical System? - Lost Coast Outpost - July 19th, 2020
- Nanomedicine Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 - 3rd Watch... - July 19th, 2020
- Nanomedicine Market 2020 Industry Share, Size, Consumption, Growth, Top Manufacturers, Type and Forecast to 2028 Bulletin Line - Bulletin Line - July 19th, 2020
- Nanomedicine Market 2020 Recent Industry Developments and Growth Strategies Adopted by Top Key Players Worldwide and Assessment to 2025 Bulletin Line... - July 18th, 2020
- What is nanomedicine? | ETPN - July 18th, 2020
- Nanosensors Market to Remain Balanced During the the COVID-19 Period - Cole of Duty - July 18th, 2020
- Nanomedicine Market 2020 Industry Share, Size, Consumption, Growth, Top Manufacturers, Type and Forecast to 2028 - Bulletin Line - July 18th, 2020
- New Comprehensive Report on Nanomedicine Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like - Jewish Life News - July 14th, 2020
- Healthcare Nanotechnology Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 -... - July 14th, 2020
- Report: New PET radiotracer proven safe and effective in imaging malignant brain tumors - Tdnews - July 13th, 2020
- Value of Healthcare Nanotechnology (Nanomedicine) Market Predicted to Surpass US$ by the of 2075 2015 2021 - Bulletin Line - July 13th, 2020
- Potential Impact of COVID-19 on Research report explores the Healthcare Nanotechnology (Nanomedicine) Market for the forecast period, 2020-2026 -... - July 12th, 2020
- New nanomedicines for mRNA therapeutics in breast cancer and heart failure - Mirage News - July 12th, 2020
- New Comprehensive Report on Antibacterial Nano Coatings Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like Nanogate AG,... - July 12th, 2020
- Nanomedicine Market with Emerging Trends, Global Scope and Demand 2020 to 2026 - The Canton Independent Sentinel - July 11th, 2020
- 3D Printed Medicine Uses Fish Gelatin to Deliver Cancer Treatment - 3DPrint.com - July 11th, 2020
- INBRAIN Neuroelectronics receives funding to push forward the development of graphene-based implants for brain disorders - Graphene-Info - June 14th, 2020
- Nanotechnology for Healthcare Market Global Competitions and Business Outlook 2020 to 2026 - News Collective - June 14th, 2020
- Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prod | DDDT - Dove Medical Press - June 14th, 2020
- Medical Biomimetics - Market Research | Recent Trends and Growth Forecast 2025 - CueReport - June 14th, 2020
- 'Laser tweezers' in nano lab used in search for drug to prevent COVID-19 replication - The Province - May 3rd, 2020
- Missouri Indian American Professor Develops Disinfecting Tunnel to Kill Viral Infections Using Silver Nano-particles - India West - May 3rd, 2020